Get my own profile
Public access
View all25 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Loredana SantoNational Center for Health Statistics, CDCVerified email at cdc.gov
- John GribbenProfessor of Medical Oncology, Queen Mary University of LondonVerified email at qmul.ac.uk
- Francesca CottiniOhio State UniversityVerified email at osumc.edu
- Ruben CarrascoVerified email at partners.org
- Jana JakubikovaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolVerified email at dfci.harvard.edu
- mariateresa fulcinitidana farber cancer instituteVerified email at dfci.harvard.edu
- Scott RodigProfessor of Pathology, Brigham & Women's HospitalVerified email at bwh.harvard.edu
- Donna NeubergDana-Farber Cancer InstituteVerified email at jimmy.harvard.edu
- Aldo RoccaroASST Spedali Civili di Brescia, Brescia, ItalyVerified email at asst-spedalicivili.it
- Marco LadettoAO ss Antonio e Biagio e Cesare ArrigoVerified email at ospedale.al.it
- Mario BoccadoroEmeritus Professor of Hematology, University of Torino, ItalyVerified email at unito.it
- Thierry AlcindorMcGill UniversityVerified email at mcgill.ca
- Irene GhobrialDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- john C. ByrdDistinguished University Professor, The Ohio State UniversityVerified email at osumc.edu
- Amy J JohnsonVincerx PharmaVerified email at vincerx.com
- Kamal PuriOncoResponse Inc.Verified email at oncoresponseinc.com
- Michele CavoProfessor of HematologyVerified email at unibo.it
- Carlo CroceProfessor, Ohio State UniversityVerified email at osumc.edu
- Siobhan V GlaveyDana Farber Cancer InstituteVerified email at stjames.ie
- Michele Moschetta, MD PhDExecutive Director, Early Clinical Development Oncology, AstraZenecaVerified email at astrazeneca.com
Follow
Güllü Topal Görgün
Executive Director, Sr.Global Project Leader, Hematology AstraZeneca, Waltham, MA, USA
Verified email at astrazeneca.com - Homepage